Opendata, web and dolomites

MOAB SIGNED

Miniaturised optically accessible bioreactor for drug discovery and biological research

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOAB project word cloud

Explore the words cloud of the MOAB project. It provides you a very rough idea of what is the project "MOAB" about.

frame    nichoid    vivo    obsolete       original    therapeutic    size    cog    fluid    patients    drug    consolidator    anymore    cancer    identification    erc    pathologies    pharmaceutical    cell    occurring    vitro    grant    radically    perfusion    extended    companies    actionable    nano    diagnostics    neurodegeneration    flat    billion    poc       discovery    chamber    96    stem    substrate    covered    tested    move    3d    subjected    lab    demonstrations    single    confirmed    dimensions    patent    few    strategy    post    valorising    millimetres    cultivation    bioreactor    lasts    inventions    context    continuous    animals    time    culture    cultured    accessible    agents    suitable    regulatory    market    modified    added    fact    accommodate    originated    interactions    dish    miniaturised    ipr    clinical    trial    commercial    moab    patterned    integrating    animal    efficacy    device    infusion    italian    medium    drugs    perform    dynamics    optically    measured    organoids    feasibility    populations    99    approvals    patents    pct    ten   

Project "MOAB" data sheet

The following table provides information about the project.

Coordinator
POLITECNICO DI MILANO 

Organization address
address: PIAZZA LEONARDO DA VINCI 32
city: MILANO
postcode: 20133
website: www.polimi.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    POLITECNICO DI MILANO IT (MILANO) coordinator 105˙000.00
2    UNIVERSITA' DEGLI STUDI DI BERGAMO IT (BERGAMO) participant 45˙000.00

Map

 Project objective

The problem that we address is that the pharmaceutical companies do not develop radically new drugs anymore, because the development process lasts ten years and costs around one billion euro. Development of a new drug is subjected to regulatory approvals following three demonstrations: lab discovery in vitro, animal testing in vivo and clinical trial on patients. This process has 99.9% overall failure, of which 96.4% because the drug efficacy measured in vitro is not confirmed in animals. In fact, the most widespread technology used to test therapeutic agents in vitro, a flat culture dish in which single cell populations are cultured and the drug to be tested is added to the culture, is obsolete. In many pathologies such as cancer and neurodegeneration, in vivo response to drugs is based on complex interactions, occurring in three-dimensions (3D) between several cell populations. To solve this problem, in the context of an ERC consolidator grant (CoG) that I currently lead, I integrated a novel nano-patterned 3D substrate for stem cell culture, called the “nichoid”, into an existing miniaturised optically accessible bioreactor (MOAB). The MOAB allows to culture 3D organoids of few millimetres in size, under continuous perfusion of the culture medium, infusion of the drug to be tested and diagnostics of cell response both in real time and also post-cultivation. Both the original inventions (the nichoid and the MOAB) are covered by Italian patents originated in the frame of the CoG project and already extended as PCT. The goal of this PoC proposal is to perform a technical and commercial feasibility to move to the market the MOAB device integrating the nichoid-patterned substrate. I will characterize the fluid-dynamics of the bioreactor chamber that has been modified to accommodate the nichoid substrate. Also, I will set a market assessment and an actionable IPR strategy with identification of a suitable exploitation strategy for valorising the patent/know how.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ENUF (2019)

Evaluation of Novel Ultra-Fast selective III-V Epitaxy

Read More  

HydroLieve (2018)

A long-lasting non-migrating hydrogel for relieving chronic pain

Read More  

Aware (2019)

Aiding Antibiotic Development with Deep Analysis of Resistance Evolution

Read More